SlideShare a Scribd company logo
FORMULATIONAND CHARACTERIZATION OF THE
METFORMINHCL MICROSPHERES
prepared
by
Kota.sriram & vanguri anil
INTRODUCTION
 To obtain maximum therapeutic efficacy, it becomes
necessary to deliver the agent to the target tissue in the
optimal amount in the right period of time there by
causing little toxicity and minimal side effects.
 There are various approaches in delivering a
therapeutic substance to the target site in a sustained
controlled release fashion.
 One such approach is using microspheres as carriers for
drugs. The development of new delivery systems for the
controlled release of drugs is one of the most interesting
fields of research in pharmaceutical sciences
 A well designed controlled drug delivery system can overcome
some of the problems of conventional therapy and enhance the
therapeutic efficacy of a given drug.
 To obtain maximum therapeutic efficacy, it becomes
necessary to deliver the agent to the target tissue in the optimal
amount in the right period of time there by causing little
toxicity and minimal side effects.
 There are various approaches in delivering a therapeutic
substance to the target site in a sustained controlled release
fashion.
.
 Microsphere can be used for the controlled release of drugs,
vaccines, antibiotics, and hormones.
 advantage of the characteristics of microspheres, beyond the
basic benefits, the microspheres could provide a larger surface
area and possess an easier esti
 Albumin and gelatins are natural polymers , and poly lactic
acid and polyglycolic acids are synthetic polymers.
 Microspheres are admistered orally to sustain drug release,
and to reduce or eliminate gastrointestinal tract irritation.
Showing the picture of microspheres
Type of microspheres
 Bio adhesive Microspheres
 Magnetic Microspheres
 Floating microspheres
 Polymeric Microspheres
 Kadam N. R,et.al,(2015)[28]: Microspheres are
multiparticulate drug delivery systems which are prepared
to obtain prolonged or controlled drug delivery to improve
bioavailability, stability and to target the drug to specific
site at a predetermined rate. They are made from
polymeric waxy or other protective materials such as
natural, semi synthetic and synthetic polymers.
 Microspheres are characteristically free flowing powders
having particle size ranging from 1-1000 μm consisting of
proteins or synthetic polymers. The range of techniques for
the preparation of microspheres provides multiple options
to control as drug administration aspects and to enhance
the therapeutic efficacy of a given the drug.
Literature Review

 These delivery systems offer numerous advantages
compared to conventional dosage forms, which include
improved efficacy, reduced toxicity, improved patient
compliance and convenience. Such systems often use
macromolecules as carriers for the drugs.
 The present review highlights various types of
microspheres, different methods of preparation, its
applications and also various parameters to evaluate their
efficiency.
 Microspheres are various types like Bioadhesive
microspheres, Magnetic microspheres, Floating
microspheres, Radioactive microspheres etc...
 AIMAND OBJECTIVES
Aim: formulation and characterization of the metformin
hcl microspheres
Objectives:
 The main objective of the present study is to design
various types of Microspheres of Metformin hcl using
polymers in various ratios.
 These different types of microspheres are prepared with
respect to enhance the drug release to attain site
specific drug delivery of the dosage form.
To obtain controlled drug release for
prolonged period of time which in turn
enhance bioavailability and therapeutic
efficacy of the dosage forms.
 Improvement of Patient compliance by
reducing dosing frequency.
DRUGPROFILE
 Name: Metformin hydrochloride
 Molecular weight: 129.16 g/mol
 Molecular formula: C4H11N5
 IUPACname: 1,1-Dimethylbiguanide
 Mechanismof action
 Metformin's mechanisms of action differ from other classes of
oral antihyperglycemic agents.
 Metformin decreases blood glucose levels by decreasing
hepatic glucose production, decreasing intestinal absorption of
glucose, and improving insulin sensitivity by increasing
peripheral glucose uptake and utilization.
 These effects are mediated by the initial activation by
metformin of AMP-activated protein kinase (AMPK), a liver
enzyme that plays an important role in insulin signaling, whole
body energy balance, and the metabolism of glucose and fats.
 Activation of AMPK is required for metformin's inhibitory
effect on the production of glucose by liver cells.
 Increased peripheral utilization of glucose may be due to
improved insulin binding to insulin receptors.
 Bioavailability: 50-60% hours
 Half-life: 2hrs
 Protein binding: Minimal
 Metabolism: Hepatic
 Elimination: Urine
 Uses: Metformin is primarily used for type 2 diabetes,
MATERIALS AND EQUIMENTS
• Materials:
 Metformin hcl
 Sodium alginate
 Cacl2
• Equipments
 UV/VIS Double beam Spectrophotometer
 FTIR
 Weighing balance
 Franze diffusion cell
PLAN OF THE WORK
 Literature survey
 Pre formulation studies
 A. Preformulation study of metformin hcl
 a) Organoleptic Properties
 b) Determination of solubility
 c) Calibration curve
 d) Drug –excipient compatability studies by FTIR
 Preparation Microspheres by using various concentrations of Polymers
 Evaluation of Microspheres
METHADOLOGY
 Physical properties:
 Colour, odour, taste and appearance
 Determination of solubility
 Construction of Calibration Curve
 Preparation of Stock Solution
procedure
• Procedure:
 Metformin HCl microspheres developed by ionotropic gelation
technique. In this technique the sodium alginate is used as
polymer in different ratios in different trails.
 The drug dissolved in respective solvents such as water . First
to disperse polymer in respective solvent such as water and it
is kept on magnatic stirrar for stirring for 1 hour at 100-500
rpm. Then add the drug to the polymer solution.
 After formation polymeric viscous solution kept stirring for
30 mins on magnetic stirring. After solution is added
dropwise to the cacl2 solution with a needle and kept for
stirring till formation of the microspheres for 1 hour. After
development of the microspheres filtered and dried in a oven.
Ingridien
ts
Metformi
n hcl
Sodium
alginate
water Cacl2
F1 100 600 q.s 5%
F2 100 700 q.s 5%
F3 100 800 q.s 5%
F4 100 900 q.s 5%
F5 100 1000 q.s 5%
FORMULATIONTABLE
RESULTS
• Organoleptic characters
 Description - White crystalline powder
 Taste - Taste less
 Odour - Odour less
 Colour - White
 Solubility
 soluble in DMSO ,whater and methanol
 Calibration curve
y = 0.0187x + 0.01
R² = 0.9988
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0 20 40 60
Absorbance
concentration
abs(nm)
Linear (abs(nm))
Evaluationstudies:
• Particle size determination
showing the figure of microspheres
 %of drug content studies
 Swelling index
 In-vitro drug release studies
• Stability samples are stored at
• Accelerated: 40±20C/75±5% RH
• Intermediate: 30±20C/65±5% RH
• Long term: 25±20C/60±5% RH
 All comparative drug release profile
0
20
40
60
80
100
120
0 2 4 6 8 10
DR1
DR2
DR3
DR4
DR5
TIME
%OFDRUGRELEASE
Conclusion
 The development and characterisation of Metformin hcl
microspheres by applying method of ionotropic gelation
method.
 Before going develop the formulation the pre formulation
studies are carried out that are calibration , FTIR, physical
properties of drugs such as appearance, taste, odour, solubility.
 The FTIR conducted between drug and excipients there is no
incompatable matter is present. The formulation is developed
by using ionotropic gelation technique the sodium alginate is
used as the polymer in different concentration. F1-F5
formulations are developed .
 The developed formulations are kept under evaluation
parameters such as %of drug content,swelling index, SEM
analysis ,In-vitro drug release studies. The In-vitro drug
release studies carried out by franse diffusion cell up to
8hours. The optimised formulation under kept stability studies
for 1month there is no degradation takes place.
References
• 1. N. K. Jain, Controlled and Novel drug delivery, 04 Edition, CBS
Publishers New Delhi, India; 21, 236-237.
• 2. P.M. Dandagi, VS. Mastiholimath, M.B. Patil, M.K. Gupta,
Biodegradable microparticulate system of captopril. International
Journal of Pharmaceutics. 307, 2006, 83-88.
• 3. Chinna Gangadhar B, Shyam Sunder R., Vimal Kumar Varma.
M., Sleeva Raju M., Sai Kiran M, Formulation and Evaluation of
Indomethacin Microspheres using natural and synthetic polymers as
Controlled Release Dosage Forms. International Journal of Drug
Discovery, 2(1), 2010,8-16.
• 4. Imran Abdul Kayyum Tadwee*, Sadhana Shahi, M. Thube, Ankit
S. Review on Microspheres. International Journal of Pharmaceutical
Research Allied Sciences, 1(1), 2012, 24-33.
• 5. Saravana Kumar K., Jayachandra Reddy P., Chandra Sekhar
K.B., A Review on Microsphere for Novel drug delivery System.
Journal of Pharmacy Research, 5(1), 2012, 420-424.
Metformine power point presentation .. .slide share

More Related Content

PPT
Formulation and evaluation of
PPTX
Biopharmaceutics classification system
PPT
SEMINAR ON MANUFACTURING AND EVALUATION OF CAPSULES…
PPT
Compression and compaction
PDF
NIOSOME, ITS PREPARATION AND EVALUATION
PPTX
microspheres types , preparation and evaluation
PPTX
Chronopharmacokinetics..
PPT
FDA Data Standards An Update
Formulation and evaluation of
Biopharmaceutics classification system
SEMINAR ON MANUFACTURING AND EVALUATION OF CAPSULES…
Compression and compaction
NIOSOME, ITS PREPARATION AND EVALUATION
microspheres types , preparation and evaluation
Chronopharmacokinetics..
FDA Data Standards An Update

What's hot (20)

PPTX
Controlled drug release
PPTX
Film dosage form
PPTX
Floating drug delivery system ppt
PDF
Chapter 9 introduction to pharmacokinetic model [compatibility mode]
PPTX
Evaluation of parenterals
PPTX
compression and consolidation
PDF
Sustained and Controlled Release (SR/CR)
PPTX
Implantable Drug Delivery System
PPTX
Sustain release drug delivery system, by dr. umesh kumar sharma & arathy s a
PPTX
Approaches Of Gastro-Retentive Drug Delivery System or GRDDS
PPTX
ocular drug delivery systems
PPTX
Parameters in Preformulation Studies
PPTX
Targeted drug delivery system
PPTX
Quality control & evaluation of aerosol
PDF
Polymers in controlled release Drug Delivery System
PPTX
factors affecting dissolution rate a full view.
PDF
Pharmacokinetics variations in Disease States.
PPTX
Theories of dispersion
PPTX
Metastable polymorphism
PPTX
Preformulation Studies
Controlled drug release
Film dosage form
Floating drug delivery system ppt
Chapter 9 introduction to pharmacokinetic model [compatibility mode]
Evaluation of parenterals
compression and consolidation
Sustained and Controlled Release (SR/CR)
Implantable Drug Delivery System
Sustain release drug delivery system, by dr. umesh kumar sharma & arathy s a
Approaches Of Gastro-Retentive Drug Delivery System or GRDDS
ocular drug delivery systems
Parameters in Preformulation Studies
Targeted drug delivery system
Quality control & evaluation of aerosol
Polymers in controlled release Drug Delivery System
factors affecting dissolution rate a full view.
Pharmacokinetics variations in Disease States.
Theories of dispersion
Metastable polymorphism
Preformulation Studies
Ad

Similar to Metformine power point presentation .. .slide share (20)

PDF
Formulation and evaluation of microspheres
PPTX
Metformin & glipizide microspheres
PDF
Formulation and evaluation ofmetformin HCl micro beads by ionotropic gelation...
PPTX
Microspheres
PPTX
METFORMIN HYDROCHLORIDE
PPTX
Microspheres
PPTX
Microspheres drug delivery system
PPTX
Metformin hydrochloride
PPTX
FORMULATION AND EVALUATION OF GLIBENCLAMIDE MICROSPHERE DRUG DELIVERY SYSTEM
PPTX
Formulation and in-vitro Evaluation of Disclofenac Microspheres for Sustained...
PDF
Design, optimization and in vitro evaluation of gastroretentive hollow micros...
PDF
Formulation and Evaluation of Microspheres Containing Aceclofenac
PPT
Microencapsulation ndds roll no.01
PDF
PDF
Formulation and-evaluation-of-microspheres
PPTX
microspheres ppt.pptx
PPTX
Microspheres and magnetic
PPTX
Microspheres ppt
PDF
Floating tablet
Formulation and evaluation of microspheres
Metformin & glipizide microspheres
Formulation and evaluation ofmetformin HCl micro beads by ionotropic gelation...
Microspheres
METFORMIN HYDROCHLORIDE
Microspheres
Microspheres drug delivery system
Metformin hydrochloride
FORMULATION AND EVALUATION OF GLIBENCLAMIDE MICROSPHERE DRUG DELIVERY SYSTEM
Formulation and in-vitro Evaluation of Disclofenac Microspheres for Sustained...
Design, optimization and in vitro evaluation of gastroretentive hollow micros...
Formulation and Evaluation of Microspheres Containing Aceclofenac
Microencapsulation ndds roll no.01
Formulation and-evaluation-of-microspheres
microspheres ppt.pptx
Microspheres and magnetic
Microspheres ppt
Floating tablet
Ad

Recently uploaded (20)

PPTX
Pharma ospi slides which help in ospi learning
PDF
grade 11-chemistry_fetena_net_5883.pdf teacher guide for all student
PPTX
Week 4 Term 3 Study Techniques revisited.pptx
PDF
3rd Neelam Sanjeevareddy Memorial Lecture.pdf
PDF
O5-L3 Freight Transport Ops (International) V1.pdf
PDF
Module 4: Burden of Disease Tutorial Slides S2 2025
PDF
Mark Klimek Lecture Notes_240423 revision books _173037.pdf
PDF
BÀI TẬP BỔ TRỢ 4 KỸ NĂNG TIẾNG ANH 9 GLOBAL SUCCESS - CẢ NĂM - BÁM SÁT FORM Đ...
PPTX
PPT- ENG7_QUARTER1_LESSON1_WEEK1. IMAGERY -DESCRIPTIONS pptx.pptx
PPTX
IMMUNITY IMMUNITY refers to protection against infection, and the immune syst...
PDF
O7-L3 Supply Chain Operations - ICLT Program
PDF
Classroom Observation Tools for Teachers
PPTX
The Healthy Child – Unit II | Child Health Nursing I | B.Sc Nursing 5th Semester
PDF
ANTIBIOTICS.pptx.pdf………………… xxxxxxxxxxxxx
PDF
TR - Agricultural Crops Production NC III.pdf
PDF
FourierSeries-QuestionsWithAnswers(Part-A).pdf
PPTX
Introduction_to_Human_Anatomy_and_Physiology_for_B.Pharm.pptx
PDF
RMMM.pdf make it easy to upload and study
PPTX
Renaissance Architecture: A Journey from Faith to Humanism
PPTX
Institutional Correction lecture only . . .
Pharma ospi slides which help in ospi learning
grade 11-chemistry_fetena_net_5883.pdf teacher guide for all student
Week 4 Term 3 Study Techniques revisited.pptx
3rd Neelam Sanjeevareddy Memorial Lecture.pdf
O5-L3 Freight Transport Ops (International) V1.pdf
Module 4: Burden of Disease Tutorial Slides S2 2025
Mark Klimek Lecture Notes_240423 revision books _173037.pdf
BÀI TẬP BỔ TRỢ 4 KỸ NĂNG TIẾNG ANH 9 GLOBAL SUCCESS - CẢ NĂM - BÁM SÁT FORM Đ...
PPT- ENG7_QUARTER1_LESSON1_WEEK1. IMAGERY -DESCRIPTIONS pptx.pptx
IMMUNITY IMMUNITY refers to protection against infection, and the immune syst...
O7-L3 Supply Chain Operations - ICLT Program
Classroom Observation Tools for Teachers
The Healthy Child – Unit II | Child Health Nursing I | B.Sc Nursing 5th Semester
ANTIBIOTICS.pptx.pdf………………… xxxxxxxxxxxxx
TR - Agricultural Crops Production NC III.pdf
FourierSeries-QuestionsWithAnswers(Part-A).pdf
Introduction_to_Human_Anatomy_and_Physiology_for_B.Pharm.pptx
RMMM.pdf make it easy to upload and study
Renaissance Architecture: A Journey from Faith to Humanism
Institutional Correction lecture only . . .

Metformine power point presentation .. .slide share

  • 1. FORMULATIONAND CHARACTERIZATION OF THE METFORMINHCL MICROSPHERES prepared by Kota.sriram & vanguri anil
  • 2. INTRODUCTION  To obtain maximum therapeutic efficacy, it becomes necessary to deliver the agent to the target tissue in the optimal amount in the right period of time there by causing little toxicity and minimal side effects.  There are various approaches in delivering a therapeutic substance to the target site in a sustained controlled release fashion.  One such approach is using microspheres as carriers for drugs. The development of new delivery systems for the controlled release of drugs is one of the most interesting fields of research in pharmaceutical sciences
  • 3.  A well designed controlled drug delivery system can overcome some of the problems of conventional therapy and enhance the therapeutic efficacy of a given drug.  To obtain maximum therapeutic efficacy, it becomes necessary to deliver the agent to the target tissue in the optimal amount in the right period of time there by causing little toxicity and minimal side effects.  There are various approaches in delivering a therapeutic substance to the target site in a sustained controlled release fashion. .
  • 4.  Microsphere can be used for the controlled release of drugs, vaccines, antibiotics, and hormones.  advantage of the characteristics of microspheres, beyond the basic benefits, the microspheres could provide a larger surface area and possess an easier esti  Albumin and gelatins are natural polymers , and poly lactic acid and polyglycolic acids are synthetic polymers.  Microspheres are admistered orally to sustain drug release, and to reduce or eliminate gastrointestinal tract irritation.
  • 5. Showing the picture of microspheres
  • 6. Type of microspheres  Bio adhesive Microspheres  Magnetic Microspheres  Floating microspheres  Polymeric Microspheres
  • 7.  Kadam N. R,et.al,(2015)[28]: Microspheres are multiparticulate drug delivery systems which are prepared to obtain prolonged or controlled drug delivery to improve bioavailability, stability and to target the drug to specific site at a predetermined rate. They are made from polymeric waxy or other protective materials such as natural, semi synthetic and synthetic polymers.  Microspheres are characteristically free flowing powders having particle size ranging from 1-1000 μm consisting of proteins or synthetic polymers. The range of techniques for the preparation of microspheres provides multiple options to control as drug administration aspects and to enhance the therapeutic efficacy of a given the drug. Literature Review
  • 8.   These delivery systems offer numerous advantages compared to conventional dosage forms, which include improved efficacy, reduced toxicity, improved patient compliance and convenience. Such systems often use macromolecules as carriers for the drugs.  The present review highlights various types of microspheres, different methods of preparation, its applications and also various parameters to evaluate their efficiency.  Microspheres are various types like Bioadhesive microspheres, Magnetic microspheres, Floating microspheres, Radioactive microspheres etc...
  • 9.  AIMAND OBJECTIVES Aim: formulation and characterization of the metformin hcl microspheres Objectives:  The main objective of the present study is to design various types of Microspheres of Metformin hcl using polymers in various ratios.  These different types of microspheres are prepared with respect to enhance the drug release to attain site specific drug delivery of the dosage form.
  • 10. To obtain controlled drug release for prolonged period of time which in turn enhance bioavailability and therapeutic efficacy of the dosage forms.  Improvement of Patient compliance by reducing dosing frequency.
  • 11. DRUGPROFILE  Name: Metformin hydrochloride  Molecular weight: 129.16 g/mol  Molecular formula: C4H11N5  IUPACname: 1,1-Dimethylbiguanide
  • 12.  Mechanismof action  Metformin's mechanisms of action differ from other classes of oral antihyperglycemic agents.  Metformin decreases blood glucose levels by decreasing hepatic glucose production, decreasing intestinal absorption of glucose, and improving insulin sensitivity by increasing peripheral glucose uptake and utilization.  These effects are mediated by the initial activation by metformin of AMP-activated protein kinase (AMPK), a liver enzyme that plays an important role in insulin signaling, whole body energy balance, and the metabolism of glucose and fats.
  • 13.  Activation of AMPK is required for metformin's inhibitory effect on the production of glucose by liver cells.  Increased peripheral utilization of glucose may be due to improved insulin binding to insulin receptors.  Bioavailability: 50-60% hours  Half-life: 2hrs  Protein binding: Minimal  Metabolism: Hepatic  Elimination: Urine  Uses: Metformin is primarily used for type 2 diabetes,
  • 14. MATERIALS AND EQUIMENTS • Materials:  Metformin hcl  Sodium alginate  Cacl2 • Equipments  UV/VIS Double beam Spectrophotometer  FTIR  Weighing balance  Franze diffusion cell
  • 15. PLAN OF THE WORK  Literature survey  Pre formulation studies  A. Preformulation study of metformin hcl  a) Organoleptic Properties  b) Determination of solubility  c) Calibration curve  d) Drug –excipient compatability studies by FTIR  Preparation Microspheres by using various concentrations of Polymers  Evaluation of Microspheres
  • 16. METHADOLOGY  Physical properties:  Colour, odour, taste and appearance  Determination of solubility  Construction of Calibration Curve  Preparation of Stock Solution
  • 17. procedure • Procedure:  Metformin HCl microspheres developed by ionotropic gelation technique. In this technique the sodium alginate is used as polymer in different ratios in different trails.  The drug dissolved in respective solvents such as water . First to disperse polymer in respective solvent such as water and it is kept on magnatic stirrar for stirring for 1 hour at 100-500 rpm. Then add the drug to the polymer solution.  After formation polymeric viscous solution kept stirring for 30 mins on magnetic stirring. After solution is added dropwise to the cacl2 solution with a needle and kept for stirring till formation of the microspheres for 1 hour. After development of the microspheres filtered and dried in a oven.
  • 18. Ingridien ts Metformi n hcl Sodium alginate water Cacl2 F1 100 600 q.s 5% F2 100 700 q.s 5% F3 100 800 q.s 5% F4 100 900 q.s 5% F5 100 1000 q.s 5% FORMULATIONTABLE
  • 19. RESULTS • Organoleptic characters  Description - White crystalline powder  Taste - Taste less  Odour - Odour less  Colour - White
  • 20.  Solubility  soluble in DMSO ,whater and methanol  Calibration curve y = 0.0187x + 0.01 R² = 0.9988 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0 20 40 60 Absorbance concentration abs(nm) Linear (abs(nm))
  • 21. Evaluationstudies: • Particle size determination showing the figure of microspheres
  • 22.  %of drug content studies  Swelling index  In-vitro drug release studies • Stability samples are stored at • Accelerated: 40±20C/75±5% RH • Intermediate: 30±20C/65±5% RH • Long term: 25±20C/60±5% RH
  • 23.  All comparative drug release profile 0 20 40 60 80 100 120 0 2 4 6 8 10 DR1 DR2 DR3 DR4 DR5 TIME %OFDRUGRELEASE
  • 24. Conclusion  The development and characterisation of Metformin hcl microspheres by applying method of ionotropic gelation method.  Before going develop the formulation the pre formulation studies are carried out that are calibration , FTIR, physical properties of drugs such as appearance, taste, odour, solubility.  The FTIR conducted between drug and excipients there is no incompatable matter is present. The formulation is developed by using ionotropic gelation technique the sodium alginate is used as the polymer in different concentration. F1-F5 formulations are developed .
  • 25.  The developed formulations are kept under evaluation parameters such as %of drug content,swelling index, SEM analysis ,In-vitro drug release studies. The In-vitro drug release studies carried out by franse diffusion cell up to 8hours. The optimised formulation under kept stability studies for 1month there is no degradation takes place.
  • 26. References • 1. N. K. Jain, Controlled and Novel drug delivery, 04 Edition, CBS Publishers New Delhi, India; 21, 236-237. • 2. P.M. Dandagi, VS. Mastiholimath, M.B. Patil, M.K. Gupta, Biodegradable microparticulate system of captopril. International Journal of Pharmaceutics. 307, 2006, 83-88. • 3. Chinna Gangadhar B, Shyam Sunder R., Vimal Kumar Varma. M., Sleeva Raju M., Sai Kiran M, Formulation and Evaluation of Indomethacin Microspheres using natural and synthetic polymers as Controlled Release Dosage Forms. International Journal of Drug Discovery, 2(1), 2010,8-16. • 4. Imran Abdul Kayyum Tadwee*, Sadhana Shahi, M. Thube, Ankit S. Review on Microspheres. International Journal of Pharmaceutical Research Allied Sciences, 1(1), 2012, 24-33. • 5. Saravana Kumar K., Jayachandra Reddy P., Chandra Sekhar K.B., A Review on Microsphere for Novel drug delivery System. Journal of Pharmacy Research, 5(1), 2012, 420-424.